NCT04635800View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

May 24, 2022

Study Completion Date

May 24, 2022

Conditions
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular DegenerationRetinal Vein Occlusion
Interventions
DRUG

MHU650

MHU650 powder for solution for injection

Trial Locations (6)

21740

Novartis Investigative Site, Hagerstown

77030

Novartis Investigative Site, Houston

78793

Novartis Investigative Site, Austin

92647

Novartis Investigative Site, Huntington Beach

96813

Novartis Investigative Site, Honolulu

00612

Novartis Investigative Site, Arecibo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY